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In viva processing and antibiotic activity of microcin B17 analogs 
with varying ring content and altered bisheterocyclic sites 
Ranabir Sinha Roy, Neil L Kelleher, Jill C Milne and Christopher T Walsh 
Background: The Escherichia co/i peptide antibiotic microcin B17 (MccB17) 
contains four oxazole and four thiazole rings, and inhibits DNA gyrase. The role 
of individual and tandem pairs of heterocycles in bioactivity has not been 
determined previously. 
Results: The two tandem 4,2-bisheterocycles in MccBl7 were varied by 
expression of MccBl7 or mutants containing altered sequences at 
Gly39-Ser40-Cys41 or Gly54-Cys55-Ser56. A mixture of five-nine-ring 
MccBl7 isoforms were separated and quantitated for antibiotic potency. 
Mutagenesis of the thiazole-oxazole pair significantly affected antibiotic activity 
compared with the upstream oxazole-thiazole, which might stabilize partially 
cyclized intermediates against proteolysis. 
Conclusions: Enzymatic heterocyclization in native MccB17 occurs 
distributively. Antibiotic activity correlates with the number of rings and is 
differentially sensitive to both the location and the identity of the 4,2-tandem 
heterocycle pairs in MccBl7. Such tandem heterocycles might be useful 
pharmacophores in combinatorial libraries. 
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Introduction 
The microcin B17 (MccB17) operon, which is present in 
certain strains of Edmdia colz, is turned on in stationary 
phase and encodes seven genes (mcbABCDEFG) that are 
responsible for microcin synthesis, export and immunity 
[l,Z]. McbA, the first gene product, is a 69-amino-acid 
MccB17 precursor [3,4], that is subject to post-translational 
modification by the three-subunit McbB,C,D enzyme 
complex [S]. The latter converts two Gly-Ser, two Gly-Cys, 
a Gly-Ser-Cys and a Gly-Cys-Ser sequence in McbA (pre- 
proMccB17) into two oxazole rings, two thiazole rings, a 4,2- 
fused oxazole-thiazole ring and a 4,2-fused thiazole-oxazole 
ring, respectively [6,7]. The first 26 residues of this hetero- 
cyclic intermediate (proMccB17) are subsequently removed 
to yield mature MccB17 (Figure l), which is exported out of 
the cell by a dedicated membrane-associated ATP-binding 
cassette transporter comprised of McbE and McbF gene 
products [8]. Microcin B17 arrests DNA replication in sensi- 
tive E. coli [9]. Self-immunity is conferred on MccB17-pro- 
ducing cells by the seventh gene of the operon, m&G, by an 
as yet undetermined mechanism [8]. 
We previously overexpressed and purified the McbB,C,D 
enzyme complex (microcin B17 synthetase) [S], and have 
investigated the in vitro heterocyclization of serine and 
cysteine residues in both full-length McbA and minimal 
substrate fragments (e.g. McbA,,,). The ATP-dependent 
cyclodehydration and dehydrogenation activities of the 
enzyme have been assayed as it processes the McbA,,, 
fragment containing the first bisheterocyclization site 
(Gly39-Ser40-Cys41, in the numbering scheme of McbA, 
Figure 1) [lo]. Similar in vitro studies have illuminated the 
role of McbAim2, as an amphipathic helical propeptide [ 111, 
that is recognized with high affinity by the synthetase [ 121. 
Structure-activity relationship analyses of McbA,,, 
analogs have studied the regioselectivity and chemoselec- 
tivity of bisheterocyclization [13,14], and the stoichiometry 
of coupled ATP cleavage (five ATP molecules hydrolyzed 
per heterocycle formed, under a defined set of conditions) 
[15]. Furthermore, the facile expression and purification of 
McbAl46 homologs fused to maltose-binding protein has 
allowed the demonstration that MccB17 synthetase can 
accept ‘non-native’ Gly-Cys-Cys and Gly-Ser-Ser 
sequences in vitro to generate tandem 4,2-fused bisthia- 
zole and bisoxazole heterocycles, respectively [13]. 
Genetic evidence suggests that MccB17 targets bacterial 
DNA gyrase [16]. This enzyme catalyzes both the nega- 
tive supercoiling and the relaxation of DNA that are 
essential for DNA replication [17]. Sensitive cells exposed 
to MccB17 undergo immediate cessation of DNA synthe- 
sis followed by induction of the SOS response, indiscrimi- 
nate double-strand cleavage of DNA and cell death [9]. 
MccB17 appears to interfere with the strand nicking-reli- 
gation activity of gyrase by trapping a covalent protein- 
DNA intermediate [16]; this is analogous to the inhibition 
of bacterial type II DNA topoisomerases by antibiotics 
such as the quinolones [18]. The eight oxazole and thia- 
zole moieties in MccB17 are presumed to play a critical 
role in this process, because the rest of the molecule 
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Structure of MccBl7 and its analogs. (a) Of 
the three potential bisheterocyclic sites (A-C) 
present in the McbA precursor, only the A-site 
and B-site are processed to the 4,2-tandem 
heterocycles in mature MccBl7. Two serines 
remain uncyclized (green stars), including 
Ser52 at the C-site. (b) The library of MccBl7 
analogs generated in this study, containing 
altered heterocycles at the A-site or B-site. 
essentially constitutes a polyglycine tether. Significantly, a 
4,2-fused bisthiazole moiety in the DNA-directed antitu- 
mor drug bleomycin is known to intercalate DNA [19] or 
to bind in the minor groove [ZO]; this suggests that similar 
roles could be played by the two tandem bisheterocycles 
in MccB17. We have constructed mutants at both bishete- 
rocyclization sites of full-length McbA (Figure lb), 
expressed them in viva in the context of the complete 
MccB17 operon, isolated the product microcins and char- 
acterized them by mass spectrometry for ring content. We 
also report on the antibiotic activity of the altered 
microcins against the susceptible E. coli strain ZK4. 
Results 
Construction of mutant McbA genes 
In vitro assays of McbAIA6 fragments with purified syn- 
thetase have demonstrated that serine and cysteine permu- 
tations of the Gly39-Ser40-Cys41 sequence (the ‘A’-site, 
A-GSC) can generally be converted to the corresponding 
mono/bisheterocycles [13]. An exception was the reverse 
regioisomer (A-GCS), which yielded only the monothiazole 
product. Nevertheless, the ability to generate alternative 
bisheterocycles in McbA,_l, prompted us to extend this 
strategy to full-length McbA so that the effects on antibi- 
otic activity could be evaluated. 
As noted previously with the ~JA,-, gene fragment [lo], 
codon degeneracy and consequent mispriming in the 
polyglycine-linker-coding region hampered mutagenesis at 
the downstream A-site. Three mutant m&4 genes with 
altered A-site residues were eventually obtained using 
splicing-by-overlap extension polymerase chain reaction 
(SOE-PCR) [Zl] and unique site elimination (USE) [Z?] 
mutagenesis strategies. Together with the B-site mutants 
constructed by the same methods, a library of genes encod- 
ing full-length McbA with altered bisheterocycles (A-GSS, 
A-GCC, B-GSC, B-GSS and B-GCC), single ring deletions 
(A-GGC, B-GCG and B-GGS), and a bisheterocycle 
‘knockout’ (B-GGG) was created (Figure lb). To maximize 
the yield of mutant microcins, these genes were expressed 
in the context of the entire mccBI7 operon cloned into the 
high-copy vector, pUC19 (ptJCl9-mcBI7) [15]. 
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Microcin B17 is a mixture of heterocyclic polypeptides 
The wild-type and mutant MccB17 antibiotics were 
expressed in E. coli strain DHStx. Given that microcin pro- 
duction is stimulated by limiting nutrients [23], cultures 
were grown to stationary phase in minimal media prior to 
harvesting. For each preparation (including wild-type 
MccB 17), several products with slightly shorter retention 
times than that of the authentic microcin were also 
obtained in the high-performance liquid chromatography 
(HPLC) purification (Figures 2a and 3a). As illustrated in 
Figures 2b and 3b for wild-type MccB17 and the A-GCC 
mutant, respectively, analysis of these HPLC fractions by 
matrix-assisted laser desorption ionization-time of flight 
mass spectrometry (MALDI-TOF MS) or electrospray 
ionization-Fourier transform (ESI-FT)-MS identified the 
peptides to be partially cyclized microcins containing 1-3 
heterocycles less than the expected complement of rings 
(each oxazole or thiazole ring formed is accompanied by a 
mass decrease of 20.03 Da due to the loss of water and two 
hydrogen atoms). The deficit (A) in heterocycle content is 
hereafter included in the annotation of these peptides 
(A--‘, A-2 and so on) to distinguish them from the fully 
heterocyclized ‘native’ (A”) isoform. 
As previously noted for in vitro assays of the McbA,,, frag- 
ment [13], the observation of partially cyclized intermedi- 
ates implies that the in viva heterocyclization of full-length 
McbA is distributive rather than processive, with repetitive 
dissociation and rebinding of partially cyclized intermedi- 
ates. The resulting sample heterogeneity necessitates rigor- 
ous HPLC purification of each microcin product, and 
confirmation of ring content by mass spectrometry, so that 
comparative assays of bioeffcacy are performed with antibi- 
otics containing the full complement of heterocycles. Typi- 
cally, 3.5 mg of pure A0 microcin was obtained in >90% 
purity from 11 of culture. The yield was lower (<l mg/l 
culture) for microcins containing monooxale or bisoxazole 
moieties at either bisheterocyclization site. The processing 
of additional serine residues in these mutants (A-GSS, B- 
GSS and B-GGS) probably introduced kinetic traps during 
heterocyclization, which decreased the yield of mature 
antibiotic. In support of this hypothesis, in vitro chemose- 
lectivity studies of McbA,,, have shown that oxazole rings 
are formed at least 100-fold slower than thiazole rings [13]. 
Discovery of a ninth heterocycle in MccB17 
Intriguingly, in the HPLC purification of wild-type 
MccB17 and certain mutants, a minor component (-16% 
of the total extract) eluting after the authentic microcin 
was observed to contain an extra ring, as indicated by an 
additional mass deficit of 20 Da relative to the A0 species 
in the mass spectrum, and confirmed by subsequent mass 
spectrometry (MS/MS) analysis (see below). For 
example, the observed molecular weight (Mobs) of native 
MccB17 (eluting at 17.6 min (during HPLC purification; 
Figure Za) was measured by MALDI-TOF MS to be 
Figure 2 
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Purification and characterization of wild-type MccBl7. (a) HPLC trace 
of crude MccBl7 injected on a Vydac C,, preparative reversed-phase 
column. Partially cyclized isoforms containing five-seven rings 
(A-3.-2s-') and a nine-ring (A”) MccBl 7 eluted with different retention 
times, in addition to the native eight-ring (AO) antibiotic. In this figure 
mAU stands for milli-absorbance units. (b) MALDI-TOF MS analysis of 
the HPLC fractions eluting at 16.3, 17.6 and 19.7 min, corresponding 
to the three peaks in Figure 2a. The following MccB17 [MHl+ isoforms 
were detected: nine-ring (A+‘, Mobs= 3073.9 Da, M,,,,=3073.0 Da), 
eight-ring (A”, Mobs= 3094.2 Da, M,,,,= 3094.0 Da), seven-ring (A-‘, 
Mobs= 31 14.4 Da, M,,,, = 31 14.1 Da), six-ring (A-*, Mobs= 3133.5 Da, 
M,,,,= 3134.1 Da) and five-ring (AW3, Mobs= 3152.0 Da, 
M ca,c= 3154.1 Da). Molecular ions resulting from the potassium 
adduct (AOK) and from the loss of water (AO-H,O) are also indicated 
for the eight-ring isoform. 
3093.2 Da (M,,,, = 3093.0 Da), thus verifying its eight-ring 
composition (Figure Zb). In comparison, the relative mol- 
ecular weight (M,) of material eluting at a later retention 
time (19.7 min) was 3072.9 Da, consistent with the forma- 
tion of a ninth ring in this material (Mcalc = 3073.0 Da). 
Similarly, a nine-ring isoform of the B-GSC mutant, an 
eight-ring B-GGS and a seven-ring B-GGG microcin, each 
containing an extra heterocycle compared with the A0 
product, were also isolated. In keeping with the nomen- 
clature described earlier, these derivatives are hereafter 
referred to as the A+l microcins. 
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Purification and characterization of the A-GCC and A-GSS MccBl7 
analogs. (a) HPLC traces of the crude microcins. Extracts from 300 ml 
of producer cells were purified by HPLC as described in the Materials 
and methods section. The low expression of A-GSS (blue, inset) relative 
to A-GCC (red) is evident, as is the presence of multiple isoforms. 
(b) ESI-FT spectra acquired at 9.4 Tesla for three HPLC fractions 
collected during the purification of A-GCC. Retention times are indicated 
alongside each mass spectrum. Eight-ring (A”, Mobs= 3109.00 Da, 
M,,,,= 3109.03 Da), seven-ring (A-l, Mobs= 3129.03 Da, 
M,,,,= 3129.06 Da) and six-ring (A-*, MO,,=31 49.06 Da, 
M,,,,= 3149.12 Da) isoforms were detected as shown. The nine-ring 
A+’ isoform was not observed for this MccBl7 mutant. 
The nine-ring (A++‘) MccBl7 contains three 4,2-linked 
bisheterocycles 
Two serine residues (SerSZ and Ser67) remain unprocessed 
in the mature eight-ring MccB17 antibiotic (Figure 1). 
Isolation of a nine-ring A+l microcin during the purification 
of MccB17 therefore, prompted detailed MS/MS analysis 
of this molecule to determine which serine residue was 
cyclized to the extra oxazole ring. To localize the position 
of the ninth heterocycle, triply-charged ions of A+’ MccB17 
obtained by electrospray ionization were subjected to 
MS/MS using collisionally activated dissociation (CAD) 
[24]. We have utilized this technique previously to charac- 
terize heterocycle formation in h’lcbA,,, fragments [14]. 
Such low-energy CAD results in the cleavage of different 
amide bonds within the polypeptide ions, each of which 
produces corresponding amino-terminal (‘b’) and carboxy- 
terminal (‘y’) fragments [ZS]. A comparison of the M, 
values of these fragments (20.03 Da deficit per heterocycle 
formed) with those calculated for the corresponding uncy- 
clized fragments allows the position of heterocycles to be 
determined within the primary sequence. 
The MS/MS spectrum of A +’ MccB17 (Figure 4a) yielded 
15 fragment ions (in addition to several neutral-loss peaks). 
Of these ions, six could be identified as comprising the 
b-ion series, b,-b,, (corresponding to 6-l 1-mer sequences 
from the amino terminus; Figure 4b). An additional six frag- 
ment ions corresponded to heterocycle-containing 
sequences at the carboxyl terminus (y-ions; Figure 4b). The 
three remaining ions could not be assigned to any particular 
fragment resulting from one or two amide-bond cleavages. 
Diagnostic data were obtained from the y-type ions, which 
encompass the residues that are heterocyclized in hlccB17. 
For example, the y, and y10 fragment ions had M, values 
corresponding (within error) to those of their counterparts 
in the MS/MS spectrum of A0MccB17 (40.04 and 40.02 Da 
lower than the values predicted for the uncyclized y-ion 
fragments, respectively). These data indicate that the 
carboxy-terminal ten residues in A+l MccB17 contain only 
two heterocycles (as in the native A0 microcin). Corroborat- 
ing this result, the y,, ion at -1210 W/Z (Figure 4a) reveals 
that the carboxy-terminal 16 residues of A+l MccB17 are 
identical to those in the A0 isoform, and contain four rings 
(denoted qry,h). Both observations discount the residue 
Ser67 as being the source of the ninth heterocycle. Lastly, 
ions corresponding to hry20 and 7ry2.j were observed, indicat- 
ing that the carboxy-terminal 20 and 25 residues, predicted 
to contain only five and six cyclization sites, respectively, 
actually contained an additional cyclized residue each. 
Taken together, the y-type fragment ions indicate that the 
additional ring is located predominantly (>90%) between 
residues Gly50 and Asn53, which is consistent with cycliza- 
tion of Ser52 (and riot Ser67) to an oxazole ring. 
UV spectroscopy of mutant microcins 
To date, the antibiotic activity of MccB17 has been deter- 
mined by the critical dilution method [26], with one unit 
defined as the amount of microcin present in a 10 ~1 sample 
of the highest dilution able to produce a clear zone (or halo) 
of growth inhibition on a lawn of sensitive cells [9]. Unfortu- 
nately, this method is subject to considerable error, and it is 
preferable to correlate microcin activity with the actual 
amount of antibiotic present in the assay. Given that dry 
weights of submilligram-to-milligram quantities of microcins 
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Figure 4 
MS/MS analysis of the nine-ring (A+‘) MccBl7 
isoform. (a) Full MS/MS spectrum acquired on 
a 4.7 Tesla ESI-FT MS, showing several b-type 
and y-type fragment ions produced by 
collisionally activated dissociation (CAD). 
Neutral loss peaks (due to water or ammonia 
loss) are indicated by black dots. Three ions 
(red dots) could not be assigned to fragments 
resulting from single or double amide bmond 
cleavages. The A+1 isotopic peaks for l+ 
fragment ions in the low m/z section of the 
spectrum (< 250 m/z) were absent. Hence, 
these fragment ions could not be distinguished 
from frequency spikes (‘-I). Also shown is an 
expansion of the spectrum corresponding to 
the diagnostic 2+ 7ry25 fragment ion 
(Mobs= 1841.5 Da, M,,,, = 1841.4 Da). 
(b) Schematic, summarizing the various amino- 
terminal (‘b’) and carboxy-terminal (‘y’) 
fragment ions observed during CAD of A+1 
MccBl7. The heterocycle content of each y- 
ion (inferred from its molecular mass) is, also 
shown. Cyclization of Ser52 (green star) 
results in the formation of s’yse and 7ry25 
fragment ions, each containing an extra ring 
compared to the corresponding fragments 
from native eight-ring MccB17. 
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are generally unreliable, the IJV properties of oxazole and 
thiazole moieties were exploited to estimate microcin con- 
centration, which was expressed in ‘normalized absorbance 
units’ (NAUs). We have previously demonstrated that both 
monoheterocycles and bisheterocycles in MccB17 absorb at 
240-254 nm, with the latter also absorbing at 280 nm 
because of extended ring conjugation [13]. The NAIJ of a 
microcin solution was calculated as NAU = A,,jdN, where 
AZi, is the absorbance of the solution at 254 nm, and N is 
the number of heterocycles in the microcin (N = 8 for A0 
MccB17; Table 1). For the diverse microcin analogs gener- 
ated in this study, stock solutions of pure antibiotic ranging 
from 0.6-4.0 NAU were obtained. Quantitative amino-acid 
analyses (QAA) of these solutions were conducted in paral- 
lel, which enabled the NAU values to be correlated with the 
actual antibiotic concentration’s. These conversion factors 
(summarized in Table 1) enabled spectroscopic determina- 
tion of microcin concentrations in subsequent purifications, 
typically with <15% error (as determined by QAA). In addi- 
tion, a stock solution of purified A0 MccB 17 of defined con- 
centration was assayed by the critical dilution method, and it 
was determined that one unit of activity (as defined by the 
latter) corresponds to -18.5 ng of MccB17. 
Antibiotic activity of the nine-ring (A++‘) MccB17 derivative 
Bisheterocyclization of the GlySO-CysSl-Ser52 sequence 
(hereafter referred to as the ‘Cl-site of McbA; Figure 1) in 
A+’ MccB17, and presumably in the A+’ MccB17 mutants, 
results in a molecule containing three tandem 4,Zfused 
bisheterocycles. Given that these moieties have been 
identified as probable partners for interaction with DNA, 
we anticipated an altered bioactivity for the nine-ring (A+‘) 
MccB17 compared with the native eight-ring isoform. 
Activity comparisons were obtained using the bioassay 
developed by Yorgey [27], with some modifications. 
Defined amounts of microcin (up to 1.6 pg) were spotted 
in 2 /.tl aliquots on lawns of MccB17-sensitive E. coli ZK4 
cells [6], which were then incubated for 12 h at 37°C. 
Antibiotic activity resulted in cell death and consequent 
halos of growth inhibition on the lawn (Figure Sa). Densit- 
ometric analysis of these halos was subsequently used to 
construct activity curves for each antibiotic (Figure Sb). 
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Table 1 
Quantification of microcin concentration by UV spectroscopy 
and quantitative amino acid analysis (QAA). 
MccBl7 Concentration of Microcin 
analog Number of rings (N) /NAU (FM NAU-‘) 
Wild-type MccBl 7 8 204 
A-GSS 8 220 
A-GCC 8 190 
B-GSC 8 277 
B-GSS 8 183 
B-GCC 8 334 
B-GGS 7 226 
B-GCG 7 237 
B-GGG 6 193 
Concentration was initially expressed in normalized absorbance units 
(NAU) based on the absorbance at 254 nm and the number of rings 
(N) present in the MccBl7 analog, as defined in the Results section. 
The QAA of the stock solutions enabled subsequent spectroscopic 
measurements to be converted to SI units (PM) using the listed 
conversion factors. 
An increase in microcin concentration was accompanied by 
a corresponding increase in the death of sensitive ZK4 
cells. Limited diffusion of the antibiotics through the agar 
media led to saturation of activity (quantified as halo size 
and intensity) at high microcin concentrations. It is reason- 
able to assume that the different microcins exhibit similar 
extents of diffusion, because aliquots of constant volume 
(2 ~1) were spotted on each lawn. The differences in 
growth inhibition observed at saturation, therefore, parallel 
Figure 5 
the relative efficacies of the various microcin analogs. It is 
evident from the activity curves presented in Figure Sb 
that the A+1 MccB 17 isoform exhibits -40% higher activity 
against sensitive E. co/i ZK4 cells, compared with the 
native eight-ring (A”) antibiotic. Consistent with this 
observation, the activities of other competent A+l MccB17 
analogs were also higher than those of the corresponding 
A0 products (see below). The potency of a particular 
MccB17 analog therefore correlates with the number of 
bisheterocycles present in the microcin. 
Mutagenesis of the A-site (Gly39-Ser40-Cys41) in MccBlir 
The tandem 4,2-fused oxazole-thiazole moiety at the 
A-site of native MccB17 (A-GSC) might interact with target 
DNA (for example in a ternary DNA-gyrase-microcin 
complex). We therefore constructed a single-ring mutant at 
this site (A-GGC) to investigate whether loss of the 
bisheterocycle affected bioactivity. Two double mutants 
(A-GCC and A-GSS) that would contain the bisthiazole 
moiety found in the antitumor drug bleomycin A [28] and 
the bisoxdzole fragment of the antiviral agent hennoxazole 
A [29], respectively, were also prepared. The in vitro 
bisheterocyclization of these sequences in McbA,,, has 
been previously demonstrated [ 131, and their incorporation 
in full-length hlcbA allowed the opportunity to evaluate 
the bioactivity of microcins with non-native bisheterocy- 
cles. The reverse regioisomer (A-GCS) was not investi- 
gated, because the in vitro studies had shown that the 
synthetase cannot process this sequence to completion. 
(b) 1200 fl 
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Concentration of MccBl7 (FM) 
Chemlstw & Biolc ‘9Y 
Bioassay of eight-ring and nine-ring MccBl7s. (a) Halos of growth inhibition obtained upon titration of eight-ring (A'J) MccBl 7 on a lawn of sensitive 
E. coliZK4 cells. The concentration of antibiotic that produced each halo is listed. (b) Activity curves for the A0 and A+’ isoforms of MccBl7 
obtained by densitometric integration of halos of growth inhibition of ZK4 cells. Cell death is reported in arbitrary units (U). 
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As with native MccB17, partially cyclized intermediates 
were observed during the HPLC purification of A-GCC 
(Figure 3a). Both, seven-ring (A-‘) and six-ring (Amz) 
species in addition to native (AO) A-GCC microcin were 
detected in the ESI-FT MS spectra of the HPLC frac- 
tions (Figure 3b). The net yield of mutant A-GCC 
microcin was comparable to that of wild-type MccB17, 
although very low quantities of the A-GSS mutant were 
obtained from cell cultures. This result is consistent with 
our prior observations that the in vitro processing of 
A-GSS (in the context of McbAiA,) proceeds very slug- 
gishly (-5% conversion in 24 h) [13], and that the 
chemoselectivity of synthetase-mediated heterocycliza- 
tion favors the processing of cysteine residues relative to 
serine residues [13,14]. The low abundance of microcin- 
related peptides in the expression of A-GSS indicated 
that microcin production was, severely impaired upon 
incorporation of the tandem serines at the A-site, which 
suggests that the cyclization of downstream heterocycles 
might occur only after bisheterocyclization at the A-site. 
I f  so, the A-GSS mutant sequence in full-length McbA 
probably acts as an upstream kinetic trap and impedes the 
processing of subsequent residues. 
The activity plots for the A0 A-site mutant microcins are 
presented for comparison with that of A0 MccB17 in 
Figure 6. Substitution of the A-site oxazole-thiazole moiety 
in native MccB17 with a bisthiazole ring (A-GCC) did not 
significantly affect antibiotic activity, although the bisoxa- 
zole analog (A-GSS) exhibited only 70% efficacy. Hence, 
the composition of each individual ring within a bishetero- 
cycle (oxazole versus thiazole) can influence microcin activ- 
ity. The single-ring A-GGC analog was the only construct 
for which no microcin productiomn could be detected in vZVO. 
HPLC and MS analyses of the extract failed to reveal any 
McbA-related products (data not shown), even though the 
fidelity of the expression vector was verified by oligonu- 
cleotide sequencing. In addition, no bioactivity could be 
detected in bioassays of the crude cell extracts. An alterna- 
tive in vitro strategy to obtain the A-GGC mutant was sub- 
sequently developed to circumvent these difficulties in 
antibiotic production. 
In vitro construction of the A-GGC MccB17 analog 
Single thiazole rings have been efficiently introduced into 
the A-site of McbA id6 by in v&o incubation of analogs con- 
taining Gly-Cys sequences (A-GGC and A-GCG) with 
purified synthetase [13]. This hz vitro strategy was therefore 
extended to full-length McbA to construct the A-GGC 
microcin analog. The mutant A-GGC McbA polypeptide 
was separately expressed and affinity-purified using an 
amino-terminal His, tag (Figure 7a). Upon incubation with 
affinity-purified MccB17 synthetase [lo] for 25 h, the fully 
processed A-GGC (A”) promicrocin containing seven hete- 
recycles was obtained (in addition to partially cyclized inter- 
mediates). Digestion of this Imixture with chymotrypsin 
Figure 6 
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enabled the removal of virtually the entire propeptide 
sequence by cleavage at the LeuZS-Gly26 amide bond. 
The mature antibiotic (‘a-GGC’) comprised of residues 26- 
69 of the McbA polypeptide was purified by HPLC and its 
identity was confirmed by MALDI-TOF MS (Mobs = 
3141.4 Da, M,,,, = 3140.0 Da). The additional residue 
(Gly26) retained at the amino terminus after proteolytic 
removal of the propeptide does not significantly interfere 
with microcin activity, as shown by the measurable bioactiv- 
ity of wild-type MccB17 (‘a-WT’; Figure 7b) produced by 
this route. Although titration experiments were prevented 
by the limited amounts of each microcin synthesized Zn 
citro, both a-WT and a-GGC did produce zones of growth 
inhibition on a lawn of sensitive ZK4 cells (Figure 7b). 
Mutagenesis of the B-site (Gly54-Cys55-Ser56) in MccBl7 
Unlike the A-site, which has been the focus of extensive in 
v&o analysis, the B-site thiazole-oxazole moiety of MccB17 
has remained outside the scope of systematic mutagenesis 
studies because the appropriate substrates are large and dif- 
ficult to evaluate (the B-site comprises the fifth and sixth 
residues to be cyclized out of eight). We elected to express 
and test all possible combinations of B-site bisheterocycles 
(B-GSC, B-GSS, and B-GCC) in the context of full-length 
McbA, in addition to single-ring deletions (B-GCG and 
B-GGS) and the bisheterocycle knockout (B-GGG). 
The increased importance of the native B-GCS bishetero- 
cycle to microcin activity (relative to the A-site) was 
immediately apparent in bioassays with the B-site 
mutants. hlicrocin activity was adversely affected by even 
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In vitro synthesis of a-GGC. (a) The mutant 
A-GGC Hiss-McbA fusion peptide was 
heterocyclized by incubation with affinity- 
purified MccB17 synthetase. Subsequent 
treatment with chymotrypsin released most of 
the propeptide sequence (McbA,-,,), with a 
single glycine residue retained at the amino 
terminus (the protease also cleaves five other 
upstream sites within the propeptide). The 
fully processed (seven-ring) product (a-GGC) 
encompasses residues 26-69 of McbA, and 
was purified from partially cyclrzed 
intermediates by HPLC. Native (eight-ring) 
MccB17 was also obtained from wild-type 
McbA by this route. (b) Zones of growth 
inhibition on lawns of sensitive f. coliZK4 
cells treated with the microcins generated in 
vitro. Cells were grown unperturbed (no Mcc), 
or treated with ‘wild type’ MccBl7 (a-WT) or 
the A-site monothiazole analog (a-GGC). The 
results are strictly qualitative, given that the 
limited amounts of microcin generated in vitro 
prevented the measurement of antibiotic 
concentrations in these assays. 
the slightest alteration in bisheterocycle composition or 
content at the B-site. Thus, each altered bisheterocycle 
(B-GCC, B-GSS, and even the reverse regioisomer B-GSC, 
which mimics the A-site) exhibited less than 30% activity 
relative to wild-type MccB17 (Figure 8). In turn, the B-site 
bisheterocycle mutants were typically SO-60% more active 
than analogs containing only a single oxazole or thiazole 
ring at this site (B-GCG and B-GGS). As with wild-type 
MccB17, the A+’ B-site mutant microcins exhibited Z-S- 
fold increased bioactivity relative to the corresponding A0 
antibiotic. Notable exceptions were the A+’ and A0 deriva- 
tives of the B-site knockout (B-GGG), both of which were 
completely inactive within the sensitivity limits of the 
bioassay, wherein 0.3% of the bioactivity of the most potent 
microcin (A+l MccB 17) could have been detected. 
Investigation of antibiotic uptake in microcin-sensitive cells 
Although the structure-activity studies of the A-site and 
B-site analogs described in this work implicate the bishete- 
recycle moieties as key determinants in the bioactivity of 
MccB17, the poor efficacies of mutant microcins depicted 
in Figure 8 could simply have resulted from a selectively 
decreased uptake of the altered antibiotics by sensitive 
cells. To evaluate this possibility, a bioassay that normalizes 
for antibiotic uptake was utilized as the second probe for 
microcin activity. Cell membranes were first permeabilized 
by treatment with toluene, which allows the free passage of 
small molecules (including microcins) into the cell. Replica- 
tive DNA synthesis was subsequently assayed in &UO using 
a modified assay originally developed by Moses [30], which 
measures the incorporation of labeled [c@P]dTTP into 
genomic DNA. Given that the antibiotic stalls DNA syn- 
thesis, lower rates of nucleotide incorporation would be 
anticipated in the presence of exogenous microcins. A com- 
parison of these rates with the bioassay data for the mutant 
microcins depicted in Figure 8 reveals whether or not 
bisheterocycle moieties were important for antibiotic 
uptake by transport proteins in nonpermeabilized cells. 
The rates of replicative DNA synthesis in toluene-perme- 
abilized E. co/i ZK4 cells that were exposed to wild-type 
A0 hlccB17 and various A”B-site mutants are presented in 
Figure 9. The microcin concentration in these assays 
(125 PM) produced at least 95% of the antibiotic activity 
observed at saturation in the corresponding lawn bioas- 
says (Figure 8) and was high enough to detect even low 
levels of inhibition of DXA synthesis. All four deoxynu- 
cleotide triphosphates were included in the assay, in 
addition to magnesium ions, potassium ions and ATP. 
LJnder these conditions, wild-type A0 lllccRl7 completely 
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Activity curves for A+’ and A0 isoforms of wild-type MC&I 7 and the 
various B-site analogs. 
abolished DNA replication as indicated by the absence of 
radiolabel in trichloroacetic aleid (TCA)-precipitates of 
the genomic material. In comparison, control cells that 
were not exposed to antibiotic exhibited time-dependent 
incorporation of [o@P]dTTP (Figure 9), which is consis- 
tent with in vz& semiconservative DNA synthesis under 
the assay conditions 1301. 
Four mutant microcins (B-GGG, B-GCC, B-GCG, and 
B-GSC) that span the spectrum of bioactivity observed 
with the B-site analogs were assayed for their effects on in 
viva DNA synthesis. Significantly, these microcins contin- 
ued to exhibit low levels of bioactivity despite free diffu- 
sion of the antibiotics into the sensitive cells (-16% 
inhibition of DNA synthesis, which is barely significant, 
given the limited sensitivity of the assay). The observed 
differences in bioefficacy between the mutant microcins 
(3-4%) is within the experimental error of the assay 
(-11%). The data confirm that the poor bioefficacy of the 
mutant microcins is not due to limited uptake of the 
altered antibiotics by the sensitive cells, but results from 
impaired interactions of the drugs with their target. 
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Inhibition of replicative DNA synthesis in ZK4 cells treated with 
MccBl7 or different B-site mutants. Rates of in viva DNA synthesis 
were obtained by measuring the incorporation of radiolabeled dTTP in 
toluene-permeabilized ZK4 cells (no Mcc), and in similar cells exposed 
to 150 f.tM antibiotic. 
To further investigate the sensitivity of replicative DNA 
synthesis to exogenous microcin, the assays that had 
been conducted at a fixed concentration of antibiotic 
were repeated over a range of concentrations for native 
(A(i) MccBl7 and the corresponding B-GCC (bisthiazole) 
analog. As illustrated in Figure 10, the titration of native 
h3ccB17 into permeabilized E. co/i ZK4 cells gave a 
linear dose-response for inhibition of DNA replication 
(ICY, -64 @vl). In contrast, the inhibition of DNA repli- 
cation by B-GCC could not be increased above 20% 
(Figure lo), even with millimolar concentrations of 
antibiotic (data not shown). 
Bioassays of mutant microcins with MccB17-resistant E. co/i 
Genetic studies have revealed that an Arg751-+Trp point 
mutation in the B subunit of DNA gyrase (the presumed 
cellular target of hIccB17) confers resistance to this antibi- 
otic [16]. The E. co/i strain VMll containing this mutation 
in gyrB does not show detectable growth inhibition upon 
exposure to high concentrations of wild-type A0 MccB17 
(up to 250 PM) in a lawn bioassay similar to the one 
described earlier (data not shown). To investigate whether 
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Inhibition of replicative DNA synthesis in ZK4 cells upon titration 
with MccBl7 or B-GCC. Wild-type MccB17 completely inhibits 
DNA synthesis (IC,, -64 FM), whereas the inhibition by B-GCC 
saturates at -20%. 
this resistance may have arisen from altered interactions 
between the native bisheterocycles in MccB17 and 
residues in the mutant GyrB protein (Trp7.51 in particu- 
lar), each A-site and B-site microcin analog was bioassayed 
on a lawn of VMll cells. Bioactivity of certain microcin 
analogs against VMll would be anticipated if the corre- 
sponding A-site or B-site heterocycles could circumvent 
the protection afforded by the change at residue 751 in 
GyrB. As with wild-type MccB17, however, none of the 
mutants generated in this study (including their A+’ iso- 
forms) exhibited bacteriocidal or bacteriostatic properties 
against VM11 (data not shown). Hence, the mechanism of 
resistance conferred by the Arg751-+Trp mutation in 
GyrB cannot be bypassed by any of the mutations at the 
A-, B- and C-bisheterocyclization sites of MccB17. 
Discussion 
The molecular basis of interactions between oxazole and 
thiazole rings (present in natural products such as the 
antitumor agent bleomycin [28], the protein synthesis 
inhibitor GE2270A [31], and the antibacterial MccBl7 
[32]) and their diverse DNA, RNA, and protein targets is 
poorly understood. A particular feature to note is the fre- 
quent occurrence of tandem 4,2-linked bisheterocycles in 
these molecules, derived from the biosynthetic double 
cyclodehydration of adjacent cysteine and serine 
residues. In bleomycin, a 4,Z-bisthiazole moiety interca- 
lates DNA [19] and is also proposed to function as a 
minor-groove-binding element [ZO]. MccB 17 has two 
such 4,2-tandem heterocycles in its complement of eight 
heterocycles: the thiazole-oxazole pair at the A-site 
(derived from Gly39-Ser40-Cys41) and the oxazole-thia- 
zole reverse regioisomer at the B-site (corresponding to the 
GlyS4-CysSS-Ser56 triad). Given that the genes for 
MccB17 biosynthesis (n&A), post-translational heterocy- 
clization (mcl,BCD), export (mcbEF) and immunity (m&G) 
are known, and that several attributes of the in vitro hetero- 
cyclization of McbA by the McbB,C,D enzyme complex 
are established, we have now examined the i?! vivo produc- 
tion and antibiotic activity of hlccB17 analogs containing 
altered heterocycles at the A-site and B-site. 
We have previously demonstrated that bisoxazoles and 
bisthiazoles (moieties not present in native blccB17) can 
be obtained from Gly39-Ser40-Ser41 (GSS) and Gly39- 
Cys40-Cys41 (GCC) mutant sequences introduced at the 
A-site of an McbA,,, substrate fragment by Nz vitro incu- 
bation with purified synthetase [13]. Single oxazole and 
thiazole rings have been similarly introduced using Gly- 
Ser and Gly-Cys sequences, respectively. The regioselec- 
tivity of bisheterocyclization is modulated by local 
sequence context, because a Gly39-Cys40-Ser41 mutant 
sequence in McbA,,, . IS cyclized only to the monothia- 
zole [13], whereas the otherwise identical Gly54- 
Cys55-Ser.56 B-site in full-length hlcbA is completely 
processed to the thiazole-oxazole. On the basis of these 
studies, nine full-length mutant mchil genes containing 
glycine, cysteine and serine permutations at the A-site or 
B-site were engineered to alter the pairs of 4,2-tandem 
heterocycles in the mature antibiotic (for example to 
introduce a bisthiazole pair or a single thiazole ring in 
place of the oxazole-thiazole or thiazole-oxazole pairs). 
The mutant m&A genes were expressed in the context of 
the entire mccBZ7 operon in the high-copy plasmid 
pUC19-mccBI7 [lS], which allowed enough antibiotic 
product to be expressed for purification and characteriza- 
tion by HPLC and hlS. The MS analysis was essential for 
determining the heterocycle content of microcin fractions 
separated by HPLC. A subsequent calibration of microcin 
concentrations by UV spectroscopy and quantitative 
amino-acid analysis allowed comparative analysis of 
antibiotic potency for each microcin species by quantify- 
ing bacterial cell-killing activity on agar plates. Densito- 
metric integration of the zones of growth inhibition in 
dilution assays with lawns of sensitive E. CO/I’ ZK4 cells 
gave highly reproducible saturation curves (Figures 6 and 
8) that allowed a proper comparison to be made between 
wild-type and various mutant MccB17 analogs. The 
results are summarized in Figure 11, which compares the 
maximum growth inhibition of ZK4 cells exposed to each 
antibiotic relative to the nine-ring (A+‘) MccB17. 
Unanticipated results quickly emerged, even from cul- 
tures overproducing and modifying the wild-type McbA 
sequence: multiple isoforms corresponding to partially 
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Figure 11 
Relative bioefficacies of the MccBl7 analogs 
and isoforms obtained in this study. Data 
correspond to the maximum growth inhibition 
obtained on a lawn of sensitive ZK4 cells and 
are normalized relative to the most potent 
microcin (A+’ MccB17). The bisheterocycles 
present in A+’ and A0 MccB17 are shown 
schematically, and only the altered A-sites or 
B-sites are denoted for the mutant microcins. 
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cyclized microcins were detected by HPLC and MS 
analyses. Similar species were also detected in the proto- 
typic producer strain MC41OO(pMM39), which carries the 
mccRI7 operon in the pBR322 vector (data not shown). We 
have observed the spontaneous precipitation of these 
components (and of mature MccB17 to a certain extent) in 
crude acid extracts upon overnight storage at 4”C, which 
might have prevented detection of the partially processed 
isoforms in prior studies [3]. Species with as few as five 
rings out of the normal complelment of eight heterocycles 
in MccB17 were active as antibiotics (data not shown). 
These observations suggest that thiazole and oxazole ring 
formation occurs in discrete steps and that five-, six- and 
seven-ring (A-3,-2.m1) intermediates accumulate along with 
the eight-ring (AO) mature MccBl7. 
A second unexpected result was the observation of a A+’ 
MccB17 isoform containing an extra ring. MS/MS analysis 
localized the site of this ninth ring to Ser52, which sets up 
a third 4,2-tandem bisheterocycle (thiazole-oxazole) in 
this microcin variant at the C-site (GlySO-Cys51-Se&Z). It 
appears that introduction of the extra oxazole ring might 
be a peculiarity of the excess cyclodehydration capacity of 
McbB,C,D (for example outpacing the export capacity of 
McbE,F with regard to the normal eight-ring MccB17 
product). Consistent with this hypothesis, no AC1 MccB17 
was detected in extracts of MC41OO(pMM39) cells, which 
contain a duplication of the genes for export (m&EF) and 
immunity (m&G) [8]. Nonethleless, a clear increase in 
antibiotic potency was observed in the several A+’ mutant 
microcins containing the new tandem bisheterocycle 
(30-40% higher bioefficacy relative to the corresponding 
A0 isoform). This result reinforces the thought that 
4,2-tandem heterocycles might be DNA-targeting, antibi- 
otic-inducing structural elements to be incorporated, for 
example, in the strategies for library construction of 
bioactive natural product mimetics. 
As illustrated in Figure 11, the introduction of non-native 
bisheterocycle combinations at the A-site (A-GCC and 
A-GSS) resulted in only a modest decrease in bioefficacy 
(O-30%), whereas mutagenesis at the B-site had a greater 
impact on antibiotic activity. The results for the A-site and 
B-site mutants suggest distinct functions for each bishetero- 
cycle in the mature MccBl7 antibiotic. For example, the 
low activity of B-GCC (-25%) contrasted sharply with that 
of the A-GCC mutant, the latter being indistinguishable 
from native microcin B17. Differing potencies were also 
noted for A-GSS (70%) and B-GSS (17%). In addition, 
whereas the B-site monoheterocylic and even acyclic iso- 
forms (B-GCG, B-GGS and B-GGG) could be readily 
detected and purified, the A-site monoheterocyclic mutant 
(A-GGC) yielded no detectable material in several in &IO 
attempts and had to be obtained by in vitro post-transla- 
tional modification. These results are consistent with the A- 
site heterocycles forming early in a propeptide-directed 
heterocyclization process, and stabilizing the glycine-rich 
McbA polypeptide (presumably a random coil) against pro- 
teolysis in the microcin-producing &I. co/i cell. The A-site 
4,2-fused oxazole-thiazole might fulfill this role by radically 
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altering the connectivity (and conformation) of the peptide 
backbone. The B-site tandem heterocycles subsequently 
formed could be major determinants for DNA recognition, 
as has been observed for the bisthiazole moiety in 
bleomycin. Consistent with this model, mutants contain- 
ing an intact B-site bisheterocycle (B-GCC, B-GSS and 
B-GSC) have higher antibiotic activity than the corre- 
sponding single-ring deletions (B-GCG and B-GGS), and 
the B-site knockout (B-GGG) is completely inactive. As 
yet unexplored is the antibiotic activity of MccB17 iso- 
forms lacking one or more of the isolated thiazole and 
oxazole rings present in the mature antibiotic. 
The highest bioactivity was observed with A+’ and A0 iso- 
forms of wild-type MccB17 itself, suggesting that the pair 
of bisheterocycles in this native antibiotic (derived from 
A-GSC and B-GCS) have been optimized by natural 
selection. The low abundance of the nine-ring A+l 
MccB17 derivative relative to the native eight-ring A0 
species contrasts with the measurably higher potency of 
the former. This observation, however, might reveal a 
strategy adopted by producing cells to maintain their 
selection advantage in stationary phase. Self-immunity in 
MccB17-producing cells is afforded by a combination of 
the dedicated microcin transporter comprising the McbE 
and McbF proteins, which pump the antibiotic out of the 
cell, and McbG, which confers protection against endoge- 
nous microcin [8]. Cell survival depends on a balance 
being maintained between the levels and intrinsic activity 
of endogenous microcins and the protection capacity of 
the immunity proteins. The production of a predomi- 
nantly A+l isoform appears to have been selected against, 
perhaps to avoid overwhelming the self-immunity mecha- 
nism. The combined bacteriocidal properties of the eight- 
ring MccB17 and the partially cyclized (five-seven-ring) 
intermediates is still sufficient to confer a selection advan- 
tage to the producing cells in stationary phase. 
MccBl7 is imported into E. ~0Li by an outer membrane 
porin (OmpF) and the inner membrane receptor SbmA 
[33]. As indicated by the permeabilized-cell thymidine 
incorporation assay, the low antibiotic efficacies of the 
MccB17 analogs are not due to discrimination by OmpF 
and/or SbmA against these mutants. The low efficacy 
must be due to a disruption in the recognition of intra- 
cellular targets (for example the complex of DNA with 
DNA gyrase). Given that microcin-induced inhibition of 
DNA synthesis is the progenitor of a cascade of events 
that eventually leads to cell death, the differing fates of 
cells exposed to the various B-site mutants (Figure 11) 
emphasizes the importance of the B-site bisheterocycle in 
determining the antibiotic activity of MccB17. 
The set of MccB17 analogs described herein, containing 
mutations at the tandem bisheterocyclic pair of sites, 
obtained by fermentation in multi-milligram quantities, 
and spanning a wide range of bioactivities, should be useful 
for further definition of the molecular determinants of 
microcin activity. Future objectives include the fine-tuning 
of tandem 4,Lbisheterocycles as pharmacophores and an 
extension of the degree to which these moieties can be uti- 
lized as independently portable elements of a bioactive 
compound. In addition, this collection of hlccB17 mutants 
may constitute a useful reagent set to further delineate the 
nature of the target in the bacterial cell. In this work, we 
have revalidated earlier reports that the E. ro/i strain 
bearing the Arg751+Trp mutation in GyrB is resistant to 
wild-type MccB17 (and have extended this observation to 
all the mutant microcins as well) increasing the likelihood 
that this enzyme, a known killing target of the quinolone 
antibacterial drugs, is at least one of the targets of the 
antibiotic. LJnderstanding the minimal content and place- 
ment of heterocycles in MccB17 for gyrase-DNA complex 
directed targeting may be enabled by extending this collec- 
tion of microcin analogs of varying affinity and avidiry. 
Significance 
The E. coli peptide antibiotic microcin B17 kills sensitive 
E. coli cells by accumulation of double-strand DNA 
breaks. DNA gyrase, also the target of the widely used 
antibacterial quinolone drugs, is one of the killing targets. 
The two pairs of tandem, fused 4,2-bisheterocycles 
in MccB17, arising from cyclization of internal Gly- 
Ser-Cys and Gly-Cys-Ser tripeptide sequences at the A- 
site and B-site, respectively, have been presumed to func- 
tion as DNA-targeting elements, given the precedent for 
intercalation of the comparable 4,2-bisthiazole moiety of 
bleomycin into double-stranded target DNA. We have 
addressed the effects of heterocyclic ring number, loca- 
tion and identity on microcin activity in whole cell assays, 
and compared the antibiotic potency of A-site and B-site 
MccB17 mutants in a DNA replication assay with 
toluene-permeabilized cells. In vivo production on high- 
copy plasmids allowed purification of sufficient quantities 
of wild-type and mutant MccB17 molecules to provide a 
collection of antibiotic molecules with six-nine rings in 
wild-type and five-nine rings in mutant isoforms. Analy- 
sis of these microcins established that the B-site tandem 
heterocylic pair was more important for potency than the 
A-site pair. This initial structure-function analysis will 
guide future choice of 4,2-bisheterocycles as potential 
DNA-directing and RNA-directing pharmacophores in 
combinatorial library strategies. 
Materials and methods 
Plasmids and strains 
Plasmids, pUCI 9-mccB77, (which encodes the mccB77 operon in 
the high copy pUC19 vector) and plasmid pET15b(+)His,-McbA, 
which encodes an amino-terminal His, fusion of the McbA polypeptide 
under control of the T7 promoter, have been described earlier 15,151. 
MccBl7-sensitive E. co/i strain ZK4 (MC41 OOrecA56) [6], the resis- 
tant strain VMl 1 [16] and the MccBl7-producing strain ZK4(pMM39) 
[8] have been reported elsewhere. [cr-32P]dTTP (10 mCi/ml) was pur- 
chased from Amersham. 
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Generation of mutant microcins 
Mutagenesis of the A-site in m&A was performed by SOE-PCR muta- 
genesis of plasmid pUCl9-mccB7 7, Iusing protocols described else- 
where [15]. The ‘outer’ forward and reverse primer pairs for SOE-PCR 
mutagenesis were 5’-GCTCGGTACCCGGGGATCCACTTCAGC-3 
and 5’-CACATTTCCATTGTTCCCGGGCATTACTG-3’, respectively. 
The nested mutagenic primers pairs were: 5’-GGCGGTTGCTGCGGT- 
GGTCAAGGB’ and 5’-CCACCTTGACCACCGCAGCAACCGCCG- 
CCG-3’ (for A-GCC), 5’-GGCGGCGGTGGCTGCGGTGGT- 
CAAGGT-3’ and Y-CCACCTTGACCACCGCAGCAACCGCCGCC- 
G-3’ (for A-GGC) and 5’-GGCGGTAGCAGCGGTGGTCAAGG-3’ and 
5’-CCACCTTGACCACCGCTGCTACCGCCGCCG-3’ (for A-GSS). 
The B-site mutants were constructed by USE mutagenesis using proto- 
cols described earlier [lo], or by SOE-PCR mutagenesis of plasmid 
pUCl9-mccB77. The selection primer for USE mutagenesis (elimination 
of the Sphl site) was 5’-GCACATGATGCATGCAAGCTTGGCGTAA- 
TCATGG-3’. The mutagenic primers were 5’-GGTTGCAGC-AACG- 
GTTGTGGTGGTGGAAACGGTGGC.AGC-3’ (B-GCG), 5’-GGT-TG- 
CAGCAACGGTTGTTGTGGTGGAAACGGTGGCAGC-3’ (B-GCC), 
and 5’-GTTGCAGCAACGGTAGTAGTGGTGGAAACGGTGGCAG- 
C-3’ (B-GSS). For SOE-PCR mutagenesis at the B-site, the outer 
primer pair was comprised of 5’-GCTCGGTACCCGGGGATCCACTT- 
CAGC-3’ and 5’.CACATTTCCATTGTTCCCGGGCATTACTG-3’. The 
nested mutagenic primer pairs were 5’-GCAACGGTAGTTGTGGTG- 
GAAACGGTGGCAGC-3’ and 5’CCACCGllTCCACCACAACTAC 
CGTTGCTGCAACC-3’ (B-GSC), 5’-GCAACGGTGGTGGTGGTGG- 
AAACGGTGGCAGC-3’ and 5’CCACCGTTTCCACCACCACCAC 
CGTTGCTGCAACC-3’ (B-GGG), and 5’-GCAACGGTGGTAGTGG- 
TGGAAACG-3’ and 5’CCACCGTTTCCACCACTACCACCGlTGC 
TGCAACC-3’ (B-GGS). 
Mutant plasmids were transformed into E. co/i DH5a. Cultures (75 ml) 
in LB/ampicillin (250 Kg/ml) were grown overnight at 37’C, and used to 
inoculate 2 I M63/ampicillin (250 ug/ml) minimal media supplemented 
with glucose. Cultures were grown to stationary phase at 37°C (30 h), 
and maintained for an additional 5-6 h. The cells were collected by 
centrifugation and boiled in 150 ml of 100 mM acetic acid, 1 mM EDTA 
for 15 min. The clarified supernatant containing crude microcin was 
applied to a Sep-Pak C,, cartridge (Waters), which was washed with 
50 ml of 12% acetonitrile (CHsCN) containing 0.1% trifluoroacetic acid 
(TFA) to remove flavins and other weakly hydrophobic contaminants. 
The mixture of heterocyclic microcins was subsequently eluted with 
50% CHsCN, 0.1% TFA. Pure A0 (or ,4+r) microcins were obtained by 
reversed-phas HPLC purification of thlls lyophilized residue (4-23 mg) 
redissolved in dimethyl sulfoxide (DMSO) (solvent A= H,O + 0.1% 
TFA; B = CHsCN + 0.1 O/o TFA, IO-23Cl/o B over 25 min, t, = 16-21 min 
for the various microcin analogs on a Vydac Preparative C,, column). 
Individual HPLC fractions were analyzed by MALDI-TOF MS or ESI-FT 
MS to determine heterocycle content and purity. 
In vitro synthesis of a-W and c&GC 
SOE-PCR mutagenesis of plasmid pETl5b(+)His,-McbA afforded the 
corresponding A-GCC McbA fusion peptide for in vitro heterocycliza- 
tion. The outer primer pair comprised 5’CCGCAAGGAATGGTTG. 
CATGCAAGG-3’ and 5’-CTCATGTITGACAGCTTATCATCG-3’. The 
nested mutagenic primer pair comprised 5’.GGCGGCGGTGGCT- 
GCGGTGGTCAAGGT-3’ and 5’.CCACCTTGACCACCGCAGCAA- 
CCGCCGCCG-3’. The wild-type and mutant Hiss-McbA fusion 
peptides were expressed in f. co/i BL21 (DE3) cells and purified by 
affinity chromatography on a Ni *+ His-bind column (Novagen) using 
protocols recommended by the manufacturer. 
In vitro heterocyclization of the Hiss-McbA fusion peptides was accom- 
plished by incubation of the substraies (70uM) with affinity-purified 
microcin Bl7 synthetase (34 Kg) in 300 ul of assay buffer- (50 mM 
Tris-HCI. DH 7.5. 100 mM NaCI. 20 mM MaCI,. 10 mM dithiothreitol 
(DTT), 2 m’M ATP) at 37°C for 25 h. Tile lyopuhil&d samples of hetero- 
cyclized His,-McbA or the cc-GGC mutant were resuspended in 100 ul 
of 50 mM Tris, pH 8.3, 1 mM EDTA. ochymotrypsin was added from a 
76 uM stock solution in the same buffer, and the digestion was 
quenched after 2-3 h at 25°C by freezing (-80°C) or injection onto a 
C,, reversed-phase column. A linear gradient of 1 O-30% CH,CN over 
40 min was applied, and the various microcin isoforms eluted from 
13-22 min, with increased ring content resulting in longer retention 
times. Completely processed isoforms of each microcin (seven-ring a- 
GGC and eight-ring a-WT) eluted at -20 min, and their identities were 
confirmed by MALDI-TOF MS analysis ((x-WT: Mobs = 3150.60 Da, 
M ca,c = 3150.10 Da; a-GGC: Mobs = 3141.40 Da, M,,,, = 3140.00 Da). 
Mass spectrometric analyses 
Aliquots (-100 ul) of fractions obtained during the HPLC purification of 
the microcins were lyophilized and the residue was dissolved in 10 ul of 
500/o CHsCN for MALDI-TOF MS analysis. The sample (1 ul) was 
spotted on a metal target, and mass spectra were acquired in reflectron 
mode on a Perseptive Biosystems Bioreflex DE STR MALDI-TOF [34] 
spectrometer using delayed extraction. Alternatively, the lyophilized 
residue was redissolved in 78:20:2 CH,CN:water:acetic acid for 
ESI-FT MS 1351 which was performed using either a 4.7 Tesla instru- 
ment at Bruker Daltonics (Billerica, MA) or a 9.4 Tesla instrument main- 
tained at the National High-Field FT-ICR User Facility [36]. Spectra 
were analyzed using GRAMMS-386 (MALDI-TOF), XMASS (4.7 T  
ESI-FT MS), or Odyssey (9.4 T  ESI-FT MS) software and theoretical 
isotopic distributions were generated using XMASS software (Bruker) 
or lsopro v.3.0 1371. 
For MS/MS analyses, samples were acidified with 2% acetic acid. The 
multiply-charged ions generated by ESI were analyzed using either a 4.7 
or a 9.4 Tesla ]36] Fourier-transform mass spectrometer. Briefly, electro- 
sprayed ions produced from either a nanospray emitter (2-4 urn orifice, 
flow rate -25-50 nl/min) [38] or a pumped flow apparatus (50 urn orifice, 
flow rate 400 nllmin) were sampled through an inlet and guided by ion 
lenses through several stages of differential pumping into the bore of a 
superconducting magnet (-lOmg Torr), wherein ions were trapped. The 
desired ions were isolated and fragmented by collisions with pulsed 
Argon gas (- 1 Om6 Torr) [24] or with infrared photons [39]. Following such 
dissociation, the fragment ions were excited and detected. The relative 
molecular weight values reported here correspond to the neutral 
monoisotopic peak. Spectra were calibrated externally using bovine ubiq- 
uitin (8559.62 Da). Two general types of ions are produced in the 
MS/MS of polypeptides, containing either the amino or carboxyl terminus 
and labeled as b-type or y-type ions, respectively 1251. Peak annotation 
indicates the number of heterocycles formed in a particular fragment ion. 
For example, 7ry25 denotes the ion corresponding to the carboxyl-terminal 
25 residues with seven rings formed (140.21 Da lower M, than that pre- 
dicted from the DNA-derived sequence). 
Determination of microcin concentration 
Stock solutions of pure microcin (0.4-l .4 mg) were made up in 50% 
CHsCN (80-28Oul), and filtered. A 2yl aliquot was diluted with 
150 ul 50% CH,CN and the absorbance at 254 nm was measured in 
a microcuvette. The absorbance of the stock solution was calculated 
from this measurement, and microcin concentration was expressed in 
NAU as described in the Results section. Quantitative amino acid 
analysis of the microcin stocks subsequently enabled antibiotic con- 
centration to be expressed in micromoles, which can be correlated to 
the NAU values as summarized in Table 1. 
Bioassay for microcin activity 
Microcin activity was measured using a modified bioassay developed 
by Yorgey 1271. The microcin-sensitive E. co/i strain ZK4 and the resis- 
tant strain VMI 1 were used as indicator strains. Lawns of cells were 
prepared by spreading -3 x 10s cells (100 ul of a 1 ml LB culture 
grown at 37°C for 5 h, mixed with 1.5 ml LB and 1.5 ml 0.8% top agar) 
on LB plates. Aliquots of stock solutions containing defined amounts of 
microcin (O-l .6 ug) were lyophilized, and the residues were redis- 
solved in 2 ul of DMSO, which were spotted on the lawns. Microcin 
concentrations in these aliquots ranged from O-250 uM. The plates 
were incubated at 37°C for 12 h and halos (zones) of growth inhibition 
were quantified from imaged plates by densitometric analysis using 
NIH Image v.l.61. Halo intensities were normalized against the plate 
background to compensate for varying exposures in the filming 
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analysis of post-translational heterocycle biosynthesis in the gyrase 
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tolerance for substitution in a GSCG cyclizable sequence. 
Biochemistry 37, 4125-4136. 
Sinha Roy, R., Kim, S., Baleja, J.D. & Walsh, CT. (1998). Role of the 
microcin Bi 7 propeptide in substrate recognition: solution structure 
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DNA gyrase inhibitor micro& B17. Mol. Microbial. 23, 161-l 68. 
Belshaw, P.J., Sinha Roy, R., Kelleher, N.L. &Walsh, CT. (1998). 
Kinetics and regioselectivity of peptide-to-heterocycle conversions by 
microcin B17 synthetase. Chem. Biol. 5, 373-384. 
8. 
9. 
10. 
11 
12. 
13. 
process. This process proved more accurate than the default practice 
of measuring halo diameters, especially when the low activity of certain 
microcin analogs resulted in weak halos due to partial growth inhibition. 
Assay for replicative DNA synthesis 
Toluene-permeabilized f. co/i ZK4 cells were prepared as described 
elsewhere [3OJ and stored at -80°C. Appropriate aliquots of stock 
solutions of the various A0 MccBl7 analogs (in 50% CH,CN) were 
lyophilized and redissolved in 5 pl of DMSO, 24 PI of DNA synthesis 
buffer (230 mM Tris HCI pH 7.5, 22 mM MgCI,, 714 mM KCI, 4 mM 
ATP, 0.955 mM P-mercaptoethanol, and 200 pM each dNTP), and 
79 pl H,O. The assay mixture was incubated at 30% for 5 min after 
the addition of 17 ~1 of toluene-treated ZK4 cells. [a-s2P]dTTP was 
subsequently added (0.12 pCi), and the assay temperature was main- 
tained at 30%. Aliquots (20 ~1) were withdrawn at appropriate time 
points and quenched with 200 pl of cold 10% TCA solution. Aliquots 
(160 ~1) of the acid quenches were loaded on a glass fiber filter using 
a 48-well slot-blot apparatus (Biorad). The filter was washed with cold 
0.01 N HCI (10 x 200 PI), and precipitated radioactivity was quantified 
using a phosphorimager. 
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